Contact Us

Cymbalta
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Date you stopped taking this drug:

Date you started taking this drug:

Name(s) of all antidepressants taken:

Age of patient when antidepressant(s) prescribed:

What condition was this medication prescribed to treat?

Was suicide attempted after taking antidepressant(s)?

Did attempted suicide result in death?

Was hospitalization or institutionalization required after taking antidepressant(s)?

Please further describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Cymbalta

FDA Says Promotions, Statements by 4 Drug Makers are Misleading

Jan 13, 2010
| Parker Waichman LLP
Four drug makers  have received Food & Drug Administration (FDA) warning letters for misleading promotions and statements about their...

Antidepressants Linked to Sudden Cardiac Death in Women

Mar 11, 2009
| Parker Waichman LLP
A new study has concluded that women with no history of cardiac problems but who use antidepressants are at an increased risk for sudden cardiac...

Lyrica, Cymbalta Fibromyalgia Promotions Questioned

Feb 9, 2009
| Parker Waichman LLP
Two drug makers are spending a fortune to promote medications for a disease that some doctors say may not even exist.  According to the...

Eli Lilly Withdraws Cymbalta Application

Dec 1, 2008
| Parker Waichman LLP
Eli Lilly and Company has announced that it withdrew an application to market Cymbalta as a treatment for chronic pain.  Reuters is reporting...

Cymbalta Suicide Data Withheld by FDA

Apr 16, 2008
| Parker Waichman LLP
Cymbalta, an antidepressant made by Eli Lilly, has been linked to suicides.  Although suicide is sometimes the tragic outcome of depression,...

Cymbalta Diabetic Nerve Pain Claims Deceptive, FDA Says

Oct 3, 2007
| Parker Waichman LLP
A new Cymbalta marketing campaign makes deceptive claims about the anti-depressant’s benefits and downplays its dangers.   Now, the...

FDA Again Warns About Suicidal Thoughts and Behavior Among Young Adults on Antidepressants

May 3, 2007
| NewsInferno.com
The U.S. Food and Drug Administration (FDA) today issued new warnings about suicidal thoughts and behavior related to young adults taking...

FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications

May 2, 2007
| www.fda.gov
The U.S. Food and Drug Administration (FDA) today proposed that makers of all antidepressant medications update the existing black box warning on...

FDA plans to expand antidepressant warning

Dec 14, 2006
| Los Angeles Times
A Food and Drug Administration federal panel Wednesday recommended the agency issue its strongest possible warning to alert patients and doctors that...

Study shows pills raise suicide risk in young adults

Dec 14, 2006
| Washington Post
Widely used antidepressants double the risk of suicidal behavior in young adults, from around three cases per thousand to seven cases per thousand,...

Page 1/2 [first] [prev] 1 2 [next] [last]